More Information: “Surfactants are important chemicals that ensure high performance and reproducibility in picodroplet-based assays”, said Dr Marian Rehak (R&D Director). “Our chemists have invented a novel range of surfactant structures which are biocompatible, highly stable and give outstanding performance on our Cyto-Cartridges™ and biochips. We have decided to patent these molecules and will add them to our emerging range of Cyto-Mine® consumables”.

More Information: “The Cyto-Cartridge™ is a unique patented biochip that can process millions of single cells in picodroplets”, said Dr Frank F. Craig (CEO). “Sphere Fluidics is further developing its IP and this trademark will add to our growing international portfolio”.